Cadence Bank Novartis Ag Transaction History

Cadence Bank

$1.5 Billion
Q2 2025

A detailed history of Cadence Bank transactions in Novartis Ag stock. As of the latest transaction made, Cadence Bank holds 5,111 shares of NVS stock, worth $676,645. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,111

Previous 5,191 1.54%

Holding current value

$676,645

Previous $578,000 6.92%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$101.96 - $121.01 $8,156 - $9,680	-80 Reduced 1.54%	5,111 $618,000
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $2,137 - $2,542	-22 Reduced 0.42%	5,191 $578,000
Q4 2024 Feb 13, 2025	SELL	$96.78 - $117.18 $31,066 - $37,614	-321 Reduced 5.8%	5,213 $507,000
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $2,122 - $2,417	-20 Reduced 0.36%	5,534 $636,000
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $12,219 - $14,172	-132 Reduced 2.32%	5,554 $591,000
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $29,533 - $33,625	-310 Reduced 5.17%	5,686 $550,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $9,780 - $10,763	-106 Reduced 1.74%	5,996 $605,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $9,188 - $10,197	-97 Reduced 1.56%	6,102 $621,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $7,401 - $8,392	-80 Reduced 1.27%	6,199 $625,000
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $61,783 - $71,649	772 Added 14.02%	6,279 $577,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $4,608 - $5,643	-61 Reduced 1.1%	5,507 $499,000
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $415,428 - $485,863	5,568 New	5,568 $424,000

Others Institutions Holding NVS

# of Institutions

1,562

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $285B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account